Natco Pharma Ltd. — Regulatory Filings 2021

Feb 26, 2021

==> picture [452 x 47] intentionally omitted <==

February 26, 2021

Corporate Relationship Department Manager – Listing M/s. BSE Ltd. M/s. National Stock Exchange of India Ltd Dalal Sreet, Fort “Exchange Plaza”, Bandra – Kurla Complex Mumbai 400 001 Bandra (E) Mumbai 400 051 Scrip Code: 524816 Scrip Code: NATCOPHARM

Dear Sir

Please find enclose herewith the Press Release for your information.

Thanking you

Yours faithfully For NATCO Pharma Limited

Digitally signed by ADINARAYANA MADINEEDI DN: c=IN, o=Personal, ADINARAYAN 2.5.4.20=98307de121abc9bab67f3e00bc3fdead0597f7b7c44a25eaab89442f8748d254, postalCode=500017, st=TELANGANA, serialNumber=3da487f04b8912870dea3f277d9 A MADINEEDI e87fc06da96e80b36d2beb1428dfe3f665de7, cn=ADINARAYANA MADINEEDI Date: 2021.02.26 11:47:08 +05'30'

M. Adinarayana Company Secretary & Vice President (Legal and Corp Affairs

Ref: PR/15 /2020-21 Press Release

==> picture [451 x 46] intentionally omitted <==

NATCO launches Brivaracetam tablets, in India, for treatment of epilepsy

Hyderabad, India, February 26[th] , 2021

Natco Pharma Limited (NSE: NATCOPHARM; BSE: 524816) is pleased to announce the launch of Brivaracetam tablets under brand BRECITA in India. Brivaracetam is indicated towards treatment of epilepsy.

Brivaracetam is developed by UCB Pharma and currently marketed in India by Dr Reddy’s under brand name Briviact®. NATCO’s BRECITA tablets will be available in two strengths of 50mg and 100mg at significantly lower MRP prices of INR 25/- and INR 35/- per tablet respectively. Epilepsy patients in India is estimated to be between 5-10 million, as per GEMIND guidelines.

---

Forwarded for favour of publication For NATCO Pharma Limited

ADINARAYANA MADINEEDI Digitally signed by ADINARAYANA MADINEEDI DN: c=IN, o=Personal, 2.5.4.20=98307de121abc9bab67f3e00bc3fdead0597f7b7c44a25eaab89442f8748d254, postalCode=500017, st=TELANGANA, serialNumber=3da487f04b8912870dea3f277d9e87fc06da96e80b36d2beb1428dfe3f665de7, cn=ADINARAYANA MADINEEDI Date: 2021.02.26 11:47:31 +05'30'

M Adinarayana Company Secretary & Vice President (Legal & Corp Affairs)